Clean Energy Technologies, Inc. entered into Securities Purchase Agreement with Noblebear Investment Holdings LLC with Noblebear Investment Holdings LLC valued at principal amount $660,000; convertible note; interest 10% per annum (effective 2026-03-06).
“On or about March 6, 2026, in consideration of (i) $604,469 in funding previously advanced to the Company by Mega Sincere Holdings Limited (“ Mega ”), a company organized under the laws of the British Virgin Islands, and its affiliates, and (ii) $600,000 in funding previously advanced to the Company by Noblebear Investment Holdings LLC (“ Noblebear ”), a company organized under the laws of the California and controlled by a Company shareholder and related party, the Company entered into securities purchase agreements with Mega and Noblebear (the “ Mega and Noblebear SPA’s ”) and issued Mega and Noblebear convertible promissory notes in the principal amounts of $664,916 and $660,000, respectively”
CETYClean Energy Technologies, Inc.
Clean Energy Technologies, Inc. entered into Securities Purchase Agreement with Mega Sincere Holdings Limited with Mega Sincere Holdings Limited valued at principal amount $664,916; convertible note; interest 10% per annum (effective 2026-03-06).
“On or about March 6, 2026, in consideration of (i) $604,469 in funding previously advanced to the Company by Mega Sincere Holdings Limited (“ Mega ”), a company organized under the laws of the British Virgin Islands, and its affiliates, and (ii) $600,000 in funding previously advanced to the Company by Noblebear Investment Holdings LLC (“ Noblebear ”), a company organized under the laws of the California and controlled by a Company shareholder and related party, the Company entered into securities purchase agreements with Mega and Noblebear (the “ Mega and Noblebear SPA’s ”) and issued Mega and Noblebear convertible promissory notes in the principal amounts of $664,916 and $660,000, respectively”
CETYClean Energy Technologies, Inc.
Clean Energy Technologies, Inc. entered into Securities Purchase Agreement with 1800 Diagonal Lending LLC with 1800 Diagonal Lending LLC valued at principal amount $147,840; purchase price $132,000; net funding $125,000 (effective 2026-03-04).
“On or about March 4, 2026, Clean Energy Technologies, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ 1800 SPA ”) with 1800 Diagonal Lending LLC, a Virginia limited liability company (“ 1800 Diagonal ”), pursuant to which the Company sold, and 1800 Diagonal purchased, a convertible promissory note in the principal amount of $147,840 (the “ 1800 Note ”) for a purchase price of $132,000”
LIXTLIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXTE BIOTECHNOLOGY HOLDINGS, INC. amended Amended and Restated Share Exchange Agreement with Orbit Capital Inc. valued at Amends and restates the Share Exchange Agreement dated November 21, 2025 (effective 2025-11-21).
“On March 6, 2026, Lixte Biotechnology Holdings, Inc., (the “Company”), Liora Technologies Europe Ltd, a subsidiary of the Company (“Liora”) and Orbit Capital Inc., (“Orbit”), entered into an Amended and Restated Share Exchange Agreement with an effective date of November 21, 2025 (the A&R Agreement).”
KDPKeurig Dr Pepper Inc.
Keurig Dr Pepper Inc. amended Amendment No. 1 with Morgan Stanley Senior Funding, Inc. (effective 2026-03-06).
“On March 6, 2026, Keurig Dr Pepper Inc. (“KDP” or the “Company”) entered into an amendment (the “Amendment No. 1”) to its Term Loan Agreement, dated as of December 18, 2025”
NXGLNEXGEL, INC.
NEXGEL, INC. entered into Agreement with Celularity, Inc. valued at up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million (effective 2026-03-06).
“On March 6, 2026, NexGel, Inc., a Delaware corporation (the “ Company ”), entered into an Asset Purchase and Exclusive License Agreement (the “ Agreement ”) with Celularity, Inc., a Delaware corporation (the “ Licensor ”), whereby the Licensor granted to the Company an exclusive license to its commercial-stage biomaterials portfolio and certain development-stage programs as more fully described in the Agreement and the Licensor agreed to sell to the Company assets related to the portfolio (collectively, the “ Business ”). Consideration for the Business will consist of up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million upfront payment and (ii) an additional $20.0 million in potential milestone payments based on net sales targets related to the Business.”
XWINXMax Inc.
XMax Inc. entered into Securities Purchase Agreement with certain purchasers identified on the signature pages thereto valued at aggregate gross proceeds to the Company of $35,955,000 (effective 2026-03-09).
“On March 9, 2026, XMax Inc. (the “Company”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain purchasers identified on the signature pages thereto (the “ Purchasers ”), pursuant to which the Company will sell to the Purchasers in a registered direct offering, an aggregate of 8,500,000 shares (the “ Shares ”) of its common stock, par value $0.001 per share (“ Common Stock ”) at a purchase price of $4.23 per share, for aggregate gross proceeds to the Company of $35,955,000, before deducting offering expenses payable by the Company.”
Eventbrite, Inc.
Eventbrite, Inc. terminated Credit Agreement with Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as the administrative agent and collateral agent (effective 2025-08-06).
“the Company repaid all obligations outstanding under, and concurrently terminated, the Credit Agreement, dated as of August 6, 2025 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time), by and among the Company, the guarantors party thereto from time to time, the banks and other financial institutions or entities party thereto from time to time, and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, as the administrative agent and collateral agent”
CVSICV Sciences, Inc.
CV Sciences, Inc. amended Agreement with an institutional investor ("Investor") valued at aggregate outstanding principal amount of $2,256,000 (effective 2026-03-04).
“On March 4, 2026, the Company and the Investor entered into an agreement (the “Agreement”) to, among other things, amend and restate the Amended Original Note and the Second Note”
NINENine Energy Service, Inc.
Nine Energy Service, Inc. entered into Exit Loan and Security Agreement with White Oak Commercial Finance, LLC valued at $135.0 million (effective 2026-03-05).
“On the Plan Effective Date, pursuant to the Plan, the Company entered into a loan and security agreement (the “Exit Loan and Security Agreement”) with White Oak Commercial Finance, LLC, as agent, and the lenders from time to time party thereto, and on the terms and subject to the conditions set forth therein, each DIP Lender exchanged and converted on a cashless basis all of its loans under the DIP Loan and Security Agreement for loans under the Exit Loan and Security Agreement.”
TXOTXO Partners, L.P.
TXO Partners, L.P. entered into Purchase Agreement with CTOC Energy, LLC valued at approximately $123.5 million in aggregate consideration (effective 2026-03-10).
“On March 10, 2026, Cross Timbers Energy, LLC (“Cross Timbers”), a joint venture in which TXO Partners, L.P. (the “Partnership”) holds a 50% interest, announced that it has executed purchase and sale agreements with multiple private buyers to sell oil and gas properties totaling approximately $200 million in aggregate consideration (collectively, the “Cross Timbers Transactions”), including a purchase and sale agreement (the “Purchase Agreement”) with CTOC Energy, LLC (“CTOC”) for approximately $123.5 million in aggregate consideration.”
GLPIGaming & Leisure Properties, Inc.
Gaming & Leisure Properties, Inc. terminated Term Loan Credit Agreement (the "2022 Term Loan Agreement") with Wells Fargo Bank, National Association, as administrative agent, and the several banks and other financial institutions or entities party thereto (effective 2026-03-04).
“On March 4, 2026, GLP repaid in full all outstanding obligations under the Term Loan Credit Agreement among GLP, Wells Fargo Bank, National Association, as administrative agent, and the several banks and other financial institutions or entities party thereto, dated as of September 2, 2022 (the “2022 Term Loan Agreement”).”
GLPIGaming & Leisure Properties, Inc.
Gaming & Leisure Properties, Inc. amended Amendment No. 3 (the "Amendment") with Wells Fargo Bank, National Association, as administrative agent, and the several banks and other financial institutions or entities party thereto valued at $679,000,000 (effective 2026-03-04).
“On March 4, 2026, GLP Capital, L.P. (“GLP”), the operating partnership of Gaming and Leisure Properties, Inc. (“GLPI”), entered into Amendment No. 3 (the “Amendment”) to the Credit Agreement among GLP, Wells Fargo Bank, National Association, as administrative agent, and the several banks and other financial institutions or entities party thereto, dated as of May 13, 2022 (the “Credit Agreement”).”
ATPCAgape ATP Corp
Agape ATP Corp entered into Collaboration Agreement with Citadel Investment LLC (effective 2026-03-06).
“On March 6, 2026, Agape ATP Corporation (the “Company”) through its subsidiary ATPC Green Energy Sdn. Bhd. (“ATPC Green Energy”), entered into a non-exclusive collaboration agreement (“Collaboration Agreement”) with Citadel Investment LLC”
ZCSHGrayscale Zcash Trust (ZEC)
Grayscale Zcash Trust (ZEC) entered into Second Amended and Restated Declaration of Trust and Trust Agreement with CSC Delaware Trust Company (effective 2026-03-09).
“On March 9, 2026, following approval of the Proposals (as defined below), Grayscale Investments Sponsors, LLC, the sponsor (the “Sponsor”) of Grayscale Zcash Trust (ZEC) (the “Trust”), and CSC Delaware Trust Company, the trustee (the “Trustee”) of the Trust, entered into the Second Amended and Restated Declaration of Trust and Trust Agreement, dated as of March 9, 2026 (the “Second A&R Trust Agreement”).”
AMCRAmcor plc
Amcor plc entered into Indenture with U.S. Bank Trust Company, National Association valued at $1,500,000,000 aggregate principal amount (comprising $750,000,000 of 4.250% Guaranteed Senior Notes (effective 2026-03-10).
“completed the offer and sale by the Issuer of $750,000,000 aggregate principal amount of its 4.250% Guaranteed Senior Notes due 2029”
CELUCelularity Inc
Celularity Inc entered into Asset Purchase and Exclusive License Agreement with NexGel, Inc. valued at up to $35.0 million in cash (effective 2026-03-06).
“On March 6, 2026, Celularity Inc., a Delaware corporation (the “Company”), entered into an Asset Purchase and Exclusive License Agreement (the “Agreement”) with NexGel, Inc., a Delaware corporation (the “Licensee”), whereby the Company granted to the Licensee an exclusive license to its commercial-stage biomaterials portfolio and certain development-stage programs as more fully described in the Agreement and the Company agreed to sell to the Licensee assets related to the portfolio (collectively, the “Business”). Consideration for the Business will consist of up to $35.0 million in cash, subject to certain adjustments, which will include (i) a $15.0 million upfront payment and (ii) an additional $20.0 million in potential milestone payments based on net sales targets related to the Business.”
SHPHShuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. entered into Placement Agency Agreement with E.F. Hutton & Co. valued at Placement agency agreement on a reasonable best-efforts basis, with cash fee of 4.0% of gross procee (effective 2026-03-05).
“On March 5, 2026, the Company entered into a Placement Agency Agreement (the “Placement Agency Agreement”) with E.F. Hutton & Co., as placement agent (the “Placement Agent”), pursuant to which the Placement Agent agreed to act as the Company’s exclusive placement agent in connection with the Offering.”
SHPHShuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. entered into Securities Purchase Agreement with the purchasers named therein valued at The Company agreed to issue and sell 2,238,800 shares of common stock and pre-funded warrants to pur (effective 2026-03-05).
“In connection with the Offering, the Company entered into a Securities Purchase Agreement, dated March 5, 2026 (the “Purchase Agreement”), by and among the Company and the purchasers named therein, pursuant to which the Company agreed to issue and sell the shares of Common Stock and Pre-Funded Warrants.”
PASGPassage BIO, Inc.
Passage BIO, Inc. terminated Hopewell Lease Termination Agreement with Hopewell Campus Owner LLC valued at termination fee of approximately $4.8 million plus accrued rent through February 14, 2026 (effective 2026-03-04).
“On March 4, 2026, Passage Bio, Inc. (the "Company") and Hopewell Campus Owner LLC (the "Landlord") entered into a lease termination agreement (the "Termination Agreement") with respect to that certain lease agreement dated December 15, 2020 between the Company and Landlord (the "Hopewell Lease").”
OZBelpointe PREP, LLC
Belpointe PREP, LLC entered into BPOZ Tokeneke Note with 100 Tokeneke Road, LLC valued at $5,000,000 (effective 2026-03-03).
“On March 3, 2026, Belpointe PREP, LLC (“we,” “us,” “our” or the “Company”), through our indirect wholly-owned subsidiary BPOZ 100 Tokeneke Holding, LLC, a Connecticut limited liability company (“BPOZ Tokeneke”), made a loan (the “BPOZ Tokeneke Loan”) in the principal amount of $5,000,000, evidenced by a convertible promissory note (the “BPOZ Tokeneke Note”), to 100 Tokeneke Road, LLC, a Connecticut limited liability company (“Tokeneke Road”).”
EDBLEdible Garden AG Inc
Edible Garden AG Inc entered into Packaging IOA with Tetra Pak Inc. (effective 2026-03-04).
“On March 4, 2026, Edible Garden AG Incorporated (the “Company”, “we” or “us”), entered into two Interim Order Agreements (the “IOAs”) with Tetra Pak Inc. (“Tetra Pak”).”
EDBLEdible Garden AG Inc
Edible Garden AG Inc entered into Processing IOA with Tetra Pak Inc. (effective 2026-03-04).
“On March 4, 2026, Edible Garden AG Incorporated (the “Company”, “we” or “us”), entered into two Interim Order Agreements (the “IOAs”) with Tetra Pak Inc. (“Tetra Pak”).”
SSMSono Group N.V.
Sono Group N.V. entered into Pre-Funded Warrant Securities Purchase Agreement with YA II PN, Ltd. (Yorkville) valued at $2,000,004.29 (effective 2026-03-10).
“On March 10, 2026, Sono Group N.V. (the “Company”) entered into a Pre-Funded Warrant Securities Purchase Agreement, dated March 10, 2026 (the “Securities Purchase Agreement”), between the Company and YA II PN, Ltd. (“Yorkville”), for a private placement (the “Private Placement”) of securities.”
ANTXAN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. entered into Securities Purchase Agreement with certain investors valued at approximately $40 million (effective 2026-03-08).
“On March 8, 2026, AN2 Therapeutics, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Purchasers”).”
FutureTech II Acquisition Corp.
FutureTech II Acquisition Corp. amended Corrected D. Boral Note with D. Boral Capital, LLC valued at Corrected promissory note principal amount $1,475,000, contingency added (effective 2026-03-04).
“On March 4, 2026, the Company, Longevity and D. Boral corrected the mistake by executing a corrected promissory Note in the principal amount of $1,475,000 (the “Corrected D. Boral Note”).”
FutureTech II Acquisition Corp.
FutureTech II Acquisition Corp. entered into Engagement Letter with D. Boral Capital, LLC valued at D. Boral will serve as sole and exclusive financial advisor (effective 2026-03-04).
“On March 4, 2026, FutureTech II Acquisition Corp. (“FutureTech” or the “Company”) entered into an engagement letter (the “Engagement Letter”) with D. Boral Capital, LLC (“D. Boral”) pursuant to which both parties agreed that D. Boral will serve as the Company’s sole and exclusive financial advisor in connection with a De-SPAC business combination between Longevity Biomedical, Inc. (“Longevity”) and the Company (the “Business Combination”) announced in the Form S-4 registration statement dated February 14, 2025.”
GRMLGreenland Mines Ltd
Greenland Mines Ltd entered into Agreement and Plan of Merger with Greenland Mines Corp., a Delaware corporation valued at 47,000 newly issued shares of the Company’s Series C Preferred Stock (effective 2026-03-04).
“On March 4, 2026, Klotho Neurosciences, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Greenland Mines Corp., a Delaware corporation (“Greenland Mines”).”
TKOTKO Group Holdings, Inc.
TKO Group Holdings, Inc. amended Credit Agreement Amendment with Goldman Sachs Bank USA, as administrative agent valued at $900.0 million (effective 2026-03-10).
“On March 10, 2026 (the “Closing Date”), TKO Worldwide Holdings, LLC (“TKO Holdings”) (f/k/a UFC Holdings, LLC), an indirect subsidiary of TKO Group Holdings, Inc. (the “Company” or “TKO”), entered into an amendment (the “Credit Agreement Amendment”) to the First Lien Credit Agreement, dated as of August 18, 2016, among TKO Guarantor, LLC (f/k/a UFC Guarantor, LLC), as holdings, TKO Holdings, as borrower, Goldman Sachs Bank USA, as administrative agent, and the lenders party thereto”
AESIAtlas Energy Solutions Inc.
Atlas Energy Solutions Inc. entered into Global Framework Agreement with Caterpillar Inc. valued at approximately $840 million (effective 2026-03-04).
“On March 4, 2026 (the “ Effective Date ”), Atlas Energy Solutions ProjectCo, LLC (“ ProjectCo ”), a Texas limited liability company and an indirect wholly owned subsidiary of Atlas Energy Solutions Inc. (the “ Company ”), a Delaware corporation, entered into the Global Framework Agreement (the “ GFA ”) with Caterpillar Inc. (“ Caterpillar ”) pursuant to which Caterpillar will reserve approximately 1.4 gigawatts (“ Reserved Capacity ”) of incremental power generation equipment (the “ Equipment ”) and ProjectCo will commit to purchase the Equipment from certain Caterpillar authorized dealers (“ Participating Dealers ”) based on ProjectCo’s monthly demand forecast beginning on the Effective Date and ending on December 31, 2030 (the “ Term ”) for an initial total aggregate purchase obligation of approximately $840 million.”
PennantPark Private Income Fund
PennantPark Private Income Fund amended First Amendment to Senior Secured Revolving Credit Facility with CIBC Bank USA valued at Increased borrowing capacity from $65.0 million to $120.0 million (effective 2026-03-04).
“On March 4, 2026, ,PennantPark Private Income Fund SPV, LLC, a wholly-owned subsidiary of PennantPark Private Income Fund (the “Borrower”), entered into a first amendment (the “Amendment”) to its senior secured revolving credit facility, originally dated as of October 1, 2026 (the “Credit Facility”), by and among the Borrower, PennantPark Investment Advisers, LLC, as collateral manager, the lenders from time to time party thereto, CIBC Bank USA, as administrative agent, and Western Alliance Trust Company, National Association, as collateral agent. The Amendment increases the Credit Facility borrowing capacity from $65.0 million to $120.0 million.”
CLXCLOROX CO /DE/
CLOROX CO /DE/ entered into 364-Day Revolving Credit Agreement with JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association valued at $1,000,000,000 (effective 2026-03-06).
“On March 6, 2026, in connection with the purchase of all of the issued and outstanding membership interests of GOJO Industries, Inc. (“GOJO”), maker of PURELL® (the “Gojo Acquisition”), pursuant to a membership interest purchase agreement (the “Acquisition Agreement”), by and among The Clorox Company (the “Company”), GOJO Industries Holdings, Inc., GOJO and certain shareholders, the Company entered into (i) a $1,000,000,000 364-day revolving credit agreement (the “364-Day Revolving Credit Agreement”) among JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association, as administrative agents and lenders, and the other agents and lenders party thereto”
AIRTAIR T INC
AIR T INC entered into Share Purchase Agreement with Arena, the sellers party thereto (collectively, the "Sellers"), and Dirk Jan Smit, as Securityholders' Agent valued at approximately $20 million (effective 2026-03-08).
“On March 8, 2026, the Company, through Crestone Air Partners, Inc. (the “ Purchaser ” or “ Crestone ”), entered into a Share Purchase Agreement (the “ Purchase Agreement ”) with Arena, the sellers party thereto (collectively, the “ Sellers ”), and Dirk Jan Smit, as Securityholders’ Agent, pursuant to which Purchaser agreed to acquire all of the outstanding shares of Arena.”
WELLWELLTOWER INC.
WELLTOWER INC. amended Amended and Restated Credit Agreement with a consortium of 32 banks; KeyBank National Association, as administrative agent valued at $6,250,000,000 unsecured revolving credit facility (effective 2026-03-06).
“On March 6, 2026, Welltower OP LLC (the “Borrower”), a subsidiary of Welltower Inc. (the “Company”), entered into the Amended and Restated Credit Agreement, dated as of March 6, 2026 (the “Amended Credit Agreement”), with a consortium of 32 banks; KeyBank National Association, as administrative agent and L/C issuer; BofA Securities, Inc., JPMorgan Chase Bank, N.A. and Wells Fargo Securities LLC, as joint bookrunners for the Revolving A Facility and the Revolving B Facility”
EHCEncompass Health Corp
Encompass Health Corp entered into 2026 Collateral and Guarantee Agreement with Truist Bank, as collateral agent (effective 2026-03-09).
“Additionally, the Company terminated its existing collateral and guarantee agreement with Barclays and entered into the Collateral and Guarantee Agreement (the “2026 Collateral and Guarantee Agreement”), by and among the Company, certain of its subsidiaries, and Truist Bank, as collateral agent, which provides for similar terms in all material respects.”
EHCEncompass Health Corp
Encompass Health Corp terminated 2022 Credit Agreement with Barclays Bank PLC, as administrative agent and collateral agent, and various other lenders (effective 2026-03-09).
“As disclosed in Item 1.01 of this Current Report on Form 8-K, on March 9, 2026, the Company terminated the 2022 Credit Agreement and the Second Amended and Restated Collateral and Guarantee Agreement, dated November 25, 2019, by and among the Company, certain of its subsidiaries, and Barclays, as collateral agent.”
EHCEncompass Health Corp
Encompass Health Corp entered into 2026 Credit Agreement with Truist Bank, as administrative agent and collateral agent, and various other lenders valued at $1 billion (effective 2026-03-09).
“On March 9, 2026 (the “Closing Date”), Encompass Health Corporation (the “Company”) entered into the Credit Agreement (the “2026 Credit Agreement”), by and among the Company, certain of its subsidiaries, as guarantors, Truist Bank, as administrative agent and collateral agent, and various other lenders.”
ACURA PHARMACEUTICALS, INC
ACURA PHARMACEUTICALS, INC entered into Note with Abuse Deterrent Pharma, LLC valued at $100,000 (effective 2026-02-06).
“On each of February 6, 2026, February 13, 2026 and March 9, 2026, we received loans of $100,000 from Abuse Deterrent Pharma, LLC ("AD Pharma").”
HNRGHALLADOR ENERGY CO
HALLADOR ENERGY CO terminated Existing Credit Agreement with PNC Bank, National Association with PNC Bank, National Association valued at Termination effective March 5, 2026; no termination penalties (effective 2026-03-05).
“In connection with the Company’s entry into the Credit Agreement, on March 4, 2026, the Company delivered written notice to PNC Bank, National Association to terminate the Company’s Existing Credit Agreement, effective as of March 5, 2026.”
HNRGHALLADOR ENERGY CO
HALLADOR ENERGY CO entered into Credit Agreement with Texas Capital Bank valued at $75 million senior secured revolving credit facility and $45 million senior secured term loan facili (effective 2026-03-05).
“On March 5, 2026, Hallador Energy Company (the “Company”) entered into a Credit Agreement (the “Credit Agreement”), among the Company, Texas Capital Bank, as administrative agent (the “Agent”), swingline lender and letter of credit issuer, Old National Bank, as joint lead arranger and letter of credit issuer, First Financial Bank, N.A., as lender, each other lender from time to time party thereto, and each other letter of credit issuer from time to time party thereto, pursuant to which the Company obtained (i) a $75 million senior secured revolving credit facility (the “Revolving Credit Facility”) and (ii) a $45 million senior secured term loan facility (the “Delayed Draw Term Loan Facility” and, together with the Revolving Credit Facilities, the “Facilities”).”
ACMAECOM
AECOM amended Amendment No. 16 to Syndicated Facility Agreement with Bank of America, N.A. as administrative agent, swing line lender and an L/C issuer and the lenders party thereto valued at $1.5 billion revolving credit facility, $950 million term loan A facility, $500 million term loan B (effective 2026-03-10).
“On March 10, 2026 (the “ Amendment Effective Date ”), AECOM entered into that certain Amendment No. 16 to Syndicated Facility Agreement (the “ Amendment ”), by and among AECOM, as borrower, certain subsidiaries of AECOM, as guarantors, the lenders party thereto (the “ Lenders ”) and Bank of America, N.A. (the “ Administrative Agent ”) as administrative agent, swing line lender and an L/C issuer”
GELGENESIS ENERGY LP
GENESIS ENERGY LP terminated Seventh Amended and Restated Credit Agreement with Genesis Energy, L.P. valued at Termination of the Old Credit Agreement effective upon entry into the New Credit Agreement (effective 2026-03-04).
“Entry into a Material Definitive Agreement On March 4, 2026, Genesis Energy, L.P. (“ Genesis ”) entered into an Eighth Amended and Restated Credit Agreement (the “ New Credit Agreement ”), among Genesis, as the borrower, Wells Fargo Bank, National Association, as administrative agent (in such capacity, the “ Administrative Agent ”) and issuing bank, Bank of America, N.A., as syndication agent, and the lenders and other parties party thereto.”
GELGENESIS ENERGY LP
GENESIS ENERGY LP entered into Eighth Amended and Restated Credit Agreement with Wells Fargo Bank, National Association valued at $900 million senior secured revolving facility, up to $1.3 billion with lender consent (effective 2026-03-04).
“On March 4, 2026, Genesis Energy, L.P. (“ Genesis ”) entered into an Eighth Amended and Restated Credit Agreement (the “ New Credit Agreement ”), among Genesis, as the borrower, Wells Fargo Bank, National Association, as administrative agent (in such capacity, the “ Administrative Agent ”) and issuing bank, Bank of America, N.A., as syndication agent, and the lenders and other parties party thereto.”
SLMSLM Corp
SLM Corp entered into Agreement with Goldman Sachs & Co. LLC valued at $200 million (effective 2026-03-09).
“On March 9, 2026, SLM Corporation (the “Company”) entered into an accelerated share repurchase agreement with Goldman Sachs & Co. LLC ("Goldman Sachs") under which the Company will purchase $200 million of its own outstanding common stock, par value $0.20 per share (the "Common Stock").”
VLOVALERO ENERGY CORP/TX
VALERO ENERGY CORP/TX entered into Underwriting Agreement with SMBC Nikko Securities America, Inc., Citigroup Global Markets Inc., MUFG Securities Americas Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters valued at $850,000,000 aggregate principal amount of its 5.150% Senior Notes due 2036 (effective 2026-03-05).
“On March 5, 2026, Valero Energy Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with SMBC Nikko Securities America, Inc., Citigroup Global Markets Inc., MUFG Securities Americas Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein, relating to the issuance and sale of $850,000,000 aggregate principal amount of its 5.150% Senior Notes due 2036 (the “Notes”).”
UTHRUNITED THERAPEUTICS Corp
UNITED THERAPEUTICS Corp entered into Collared Accelerated Share Repurchase Agreement with Citibank, N.A. valued at $750,000,000 (effective 2026-03-09).
“Under the Collared ASR, which is being entered into pursuant to the Master Confirmation between the Company and Citi, dated August 1, 2025, the Company will receive an initial delivery of approximately 708,657 shares of Common Stock on March 11, 2026 representing approximately 50% of the total shares that would be repurchased under the Collared ASR (the Initial Delivery Amount ), measured based on the closing price of the Common Stock on March 9, 2026.”
UTHRUNITED THERAPEUTICS Corp
UNITED THERAPEUTICS Corp entered into Uncollared Accelerated Share Repurchase Agreement with Citibank, N.A. valued at $750,000,000 (effective 2026-03-09).
“Under the Uncollared ASR, which is being entered into pursuant to the Master Confirmation between the Company and Citi, dated March 25, 2024, the Company will receive an initial delivery of approximately 992,120 shares of Common Stock on March 11, 2026 representing approximately 70% of the total shares that would be repurchased under the Uncollared ASR, measured based on the closing price of the Common Stock on March 9, 2026.”
NLSTNETLIST INC
NETLIST INC amended First Amendment to Lease with University Research Park LLC (effective 2026-03-04).
“On March 4, 2026, Netlist, Inc. (the “Company”) entered into a First Amendment to Lease (the “Lease Amendment”) with University Research Park LLC (the “Landlord”), pursuant to which the Company and the Landlord agreed to renew the Company’s existing lease dated April 28, 2021 (the “Lease”), relating to the Company’s corporate headquarter located at 111 Academy, Suite 100, Irvine, CA 92617 (the “Premises”).”
BATLBATTALION OIL CORP
BATTALION OIL CORP entered into Securities Purchase Agreement with an institutional investor valued at aggregate gross proceeds of $15.0 million (effective 2026-03-03).
“On March 3, 2026, Battalion Oil Corporation (the “ Company ”), entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with an institutional investor (the “ Purchaser ”).”
XNCRXencor Inc
Xencor Inc terminated Amended and Restated Collaboration and License Agreement with Genentech, Inc. and F. Hoffmann-La Roche Ltd (effective 2026-09-04).
“On March 4, 2026, Xencor, Inc. (the “Company”) received a notice of termination of an Amended and Restated Collaboration and License Agreement (the “Agreement”), effective as of June 1, 2024, with Genentech, Inc. (“GNE”) and F. Hoffmann-La Roche Ltd (“Roche” and, GNE and Roche, collectively, “Genentech”), pursuant to which Genentech has elected to terminate the Agreement in its entirety for convenience. The effective date of the termination of the Agreement is September 4, 2026.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.